ESC Professional Premium Access

The PRELIEVE trial:Final 1-year outcomes of the prospective atrial flow regulator study

Congress Presentation

About the speaker

Doctor Christina Paitazoglou

University Heart Center, Luebeck (Germany)
1 presentation
0 follower

7 more presentations in this session

Transcatheter endomyocardial alginate-hydrogel injection for treatment of heart failure

Speaker: Doctor B. Wang (Galway, IE)

Thumbnail

Interventional rhythm control is associated with an improved long-term prognosis of patients with atrial fibrillation undergoing transcatheter edge-to-edge mitral valve repair

Speaker: Doctor C. Waechter (Marburg, DE)

Thumbnail

Tricuspid regurgitation and heart failure: the faith of treated vs untreated cohort in the percutaneous era

Speaker: Doctor E. Zancanaro (Milan, IT)

Thumbnail

Impact of sacubitril valsartan initiation in patients with HFrEF and severe mitral regurgitation referred for percutaneous mitral repair

Speaker: Mrs M. Rivadeneira Ruiz (Madrid, ES)

Thumbnail

A proactive care pathway that improves medical therapy for patients with heart failure with reduced ejection fraction and implantable cardiac devices

Speaker: Doctor H. Williams (Bristol, GB)

Thumbnail

Access the full session

Complex and novel interventions for heart failure

Speakers: Doctor C. Paitazoglou, Doctor B. Wang, Doctor C. Waechter, Doctor E. Zancanaro, Mrs M. Rivadeneira Ruiz...
Thumbnail

About the event

Image

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb